Masahiro Ayano

1.2k total citations
40 papers, 532 citations indexed

About

Masahiro Ayano is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, Masahiro Ayano has authored 40 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 21 papers in Immunology and 9 papers in Genetics. Recurrent topics in Masahiro Ayano's work include Systemic Lupus Erythematosus Research (13 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Systemic Sclerosis and Related Diseases (7 papers). Masahiro Ayano is often cited by papers focused on Systemic Lupus Erythematosus Research (13 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Systemic Sclerosis and Related Diseases (7 papers). Masahiro Ayano collaborates with scholars based in Japan and United States. Masahiro Ayano's co-authors include Takahiko Horiuchi, Hiroaki Niiro, Hiroki Mitoma, Koichi Akashi, Yojiro Arinobu, Mitsuteru Akahoshi, Yasutaka Kimoto, Hiroshi Tsukamoto, Naoyasu Ueda and Atsushi Tanaka and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Masahiro Ayano

33 papers receiving 527 citations

Peers

Masahiro Ayano

IMMUN

RHEUM

EPIDE

PFM

Haruka Tsuchiya Japan

Shuji Akizuki Japan

Clara Di Mario Italy

Cleonice Bueno Brazil

Ziyan Wu China

Ryo Hisada Japan

Yoshie Sanayama Japan

Ji-Yih Chen Taiwan

Makio Kusaoi Japan

J. von Kempis Switzerland

Haruka Tsuchiya Japan

Masahiro Ayano

196 ×0.8

IMMUN

188 ×1.0

RHEUM

111 ×1.2

80 ×0.9

EPIDE

52 ×0.6

PFM

Citations per year, relative to Masahiro Ayano Masahiro Ayano (= 1×) peers Haruka Tsuchiya

Countries citing papers authored by Masahiro Ayano

Since Specialization

Citations

This map shows the geographic impact of Masahiro Ayano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Ayano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Ayano more than expected).

Fields of papers citing papers by Masahiro Ayano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Ayano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Ayano. The network helps show where Masahiro Ayano may publish in the future.

Co-authorship network of co-authors of Masahiro Ayano

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Ayano. A scholar is included among the top collaborators of Masahiro Ayano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Ayano. Masahiro Ayano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kimura, Kôichi, Masahiro Ayano, Yasutaka Kimoto, et al.. (2024). Comparative efficacy and safety of belimumab and hydroxychloroquine in the maintenance phase in patients with systemic lupus erythematosus: a retrospective cohort study. 2.

Ayano, Masahiro, Akie Hirata, Yasutaka Kimoto, et al.. (2024). No clear influence of treatment escalation on flare prevention in serologically active clinically quiescent patients with systemic lupus erythematosus: a retrospective cohort study. Rheumatology International. 44(11). 2411–2419. 3 indexed citations

Ohmura, Hirofumi, Hiroshi Ariyama, Mamoru Ito, et al.. (2023). Case Report: Resolution of remitting seronegative symmetrical synovitis with pitting edema during nivolumab therapy for gastric cancer. Frontiers in Oncology. 13. 1260818–1260818.

Kimoto, Yasutaka, Takuya Sawabe, Masahiro Ayano, et al.. (2022). Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicentre cohort study. Modern Rheumatology. 33(2). 367–372. 9 indexed citations

Mitoma, Hiroki, Yusuke Yamauchi, Masahiro Ayano, et al.. (2022). CEACAM 1, 3, 5 and 6 -positive classical monocytes correlate with interstitial lung disease in early systemic sclerosis. Frontiers in Immunology. 13. 1016914–1016914. 8 indexed citations

Ayano, Masahiro, Yasutaka Kimoto, Hiroki Mitoma, et al.. (2021). Human PD-1hiCD8+ T Cells Are a Cellular Source of IL-21 in Rheumatoid Arthritis. Frontiers in Immunology. 12. 654623–654623. 23 indexed citations

Nakano, Miki, Masahiro Ayano, Hiroki Mitoma, et al.. (2021). Increased Proportion of CD226+ B Cells Is Associated With the Disease Activity and Prognosis of Systemic Lupus Erythematosus. Frontiers in Immunology. 12. 713225–713225. 12 indexed citations

Arinobu, Yojiro, Kohta Miyawaki, Masahiro Ayano, et al.. (2021). Autoimmune manifestations associated with myelodysplastic syndrome predict a poor prognosis. Medicine. 100(13). e25406–e25406. 8 indexed citations

Ayano, Masahiro, Keisuke Nishimura, Miki Nakano, et al.. (2021). HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study. Arthritis Research & Therapy. 23(1). 238–238.

10.

Ayano, Masahiro, Ken Yamamoto, Kōji Takayama, et al.. (2021). Infliximab for reversible dementia in acute onset of neuro-Behçet's disease: A case report and cytokine analysis. Journal of Neuroimmunology. 357. 577631–577631. 2 indexed citations

11.

Miyawaki, Kohta, Masahiro Ayano, Yasutaka Kimoto, et al.. (2020). Type 1 helper T cells generate CXCL9/10-producing T-bet+ effector B cells potentially involved in the pathogenesis of rheumatoid arthritis. Cellular Immunology. 360. 104263–104263. 22 indexed citations

12.

Ayano, Masahiro, Yojiro Arinobu, Hiroshi Tsukamoto, et al.. (2020). Shoulder ultrasound and serum lactate dehydrogenase predict inadequate response to glucocorticoid treatment in patients with polymyalgia rheumatica. Rheumatology International. 40(7). 1101–1109. 7 indexed citations

13.

Mitoma, Hiroki, Yasutaka Kimoto, Masamichi Koyanagi, et al.. (2020). Methotrexate Enhances Apoptosis of Transmembrane TNF-Expressing Cells Treated With Anti-TNF Agents. Frontiers in Immunology. 11. 2042–2042. 3 indexed citations

14.

Arinobu, Yojiro, Kohta Miyawaki, Hisakata Yamada, et al.. (2019). CCR6+ group 3 innate lymphoid cells accumulate in inflamed joints in rheumatoid arthritis and produce Th17 cytokines. Arthritis Research & Therapy. 21(1). 198–198. 41 indexed citations

15.

Ayano, Masahiro, Hiroshi Tsukamoto, Hiroki Mitoma, et al.. (2019). CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan. Arthritis Research & Therapy. 21(1). 30–30. 26 indexed citations

16.

Kiyohara, Chikako, Takuya Sawabe, Shuji Nagano, et al.. (2018). Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study. PLoS ONE. 13(4). e0196368–e0196368. 44 indexed citations

17.

Arinobu, Yojiro, Koichi Akashi, Koh‐Hei Sonoda, et al.. (2017). Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behçet’s disease. European Journal of Rheumatology. 5(1). 9–15. 10 indexed citations

18.

Tanaka, Atsushi, Hiroshi Tsukamoto, Hiroki Mitoma, et al.. (2015). Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis. Arthritis Research & Therapy. 17(1). 27–27. 17 indexed citations

19.

Ueda, Naoyasu, Hiroshi Tsukamoto, Hiroki Mitoma, et al.. (2013). The Cytotoxic Effects of Certolizumab Pegol and Golimumab Mediated by Transmembrane Tumor Necrosis Factor α. Inflammatory Bowel Diseases. 19(6). 1224–1231. 45 indexed citations

20.

Tanaka, Akihiko, Hiroshi Tsukamoto, Hiroki Mitoma, et al.. (2012). THU0168 Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity. Annals of the Rheumatic Diseases. 71. 212–212. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact